New Dry Eye Medication Approved By FDA

The chance of experiencing dry eye disease rises with age, affecting approximately 5 percent of the adult population age 30-40 and 10-15 percent of adults older than age 65; it is more common among women.

The U.S. Food and Drug Administration on July 11 approved Xiidra, an ophthalmic solution, for treating symptoms of dry eye disease, saying it is the first medication in a new class of drugs called lymphocyte function-associated antigen 1 (LFA-1) antagonists approved by FDA for dry eye disease.

"Normal tear production is needed for clear vision and eye health," explained Dr. Edward Cox, M.D., director of the Office of Antimicrobial Products in FDA's Center for Drug Evaluation and Research. The disease includes a group of conditions where the eye does not produce an adequate volume of tears or the tears are not of the correct consistency. The chance of experiencing dry eye disease rises with age, affecting approximately 5 percent of the adult population age 30-40 and 10-15 percent of adults older than age 65; it is more common among women.

Xiidra is manufactured by Shire US Inc., of Lexington, Mass. The solution's safety and efficacy were assessed in more than 1,000 patients in four separate randomized, controlled studies. The studies found that groups treated with Xiidra demonstrated more improvement in both the signs and the symptoms of eye dryness than the groups treated with a placebo.

Download Center

HTML - No Current Item Deck
  • COVID-19 Return to Work Kit

    Streamline your return to work program and ensure your employees can get back safely with these resources created by certified occupational health, safety, and infectious disease experts.

  • 9 Common Questions About Behavior-Based Safety

    Renowned workplace safety expert Dr. Andrew Sharman answers 9 of the most pressing questions EHS professionals have about behavior-based safety programs.

  • COVID-19 Employee Health Screening Toolkit

    Powerful health assessment tools designed to help occupational health practitioners, employee health departments, and health and safety professionals conduct rapid workforce health screening to reduce the risk of infection and ensure business continuity.

  • RSIGuard Home Ergonomics Software

    Ensure you and your employees can work safely from home with a 6 month free trial of the RSIGuard desktop ergonomics software.

  • 5 Reasons You Should Embrace the Cloud for EHSQ Software

    EHSQ managers can realize reduced costs, increased productivity and enhanced software reliability when using SaaS.

  • Industry Safe

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2020

    June 2020

    Featuring:

    • FIRE SAFETY
      Recognizing and Mitigating Static Electricity Hazards
    • OIL & GAS
      New Gas Detection Technology
    • HEAT STRESS
      Stop Sweating Heat Stress
    • ELECTRICAL SAFETY
      Electricity is Everywhere
    View This Issue